Key Insights
The North American blood glucose monitoring market, valued at $15.51 billion in 2025, is projected to experience robust growth, driven by a rising prevalence of diabetes and an increasing aging population. The market's Compound Annual Growth Rate (CAGR) of 13.13% from 2019 to 2024 suggests a continued upward trajectory through 2033. Key drivers include advancements in continuous glucose monitoring (CGM) systems offering improved accuracy and convenience, coupled with rising healthcare expenditure and increased awareness of diabetes management. The segment encompassing self-monitoring blood glucose devices (SMBG) continues to hold significant market share, although CGM is experiencing rapid adoption due to its ability to provide real-time glucose data. Within the end-user segment, the home/personal care sector is expected to witness substantial growth fueled by the increasing preference for self-management of diabetes. Major players such as Abbott Diabetes Care, Medtronic, and Dexcom are shaping market dynamics through innovation and strategic partnerships, further bolstering market expansion. Geographic distribution shows a concentration in the United States, owing to high diabetes prevalence and extensive healthcare infrastructure. Canada and Mexico are also contributing to market growth, though at a comparatively slower pace. However, challenges such as high device costs, particularly for CGM systems, and potential insurance coverage limitations could act as constraints on the market's overall growth in the coming years.
The forecast for the North American blood glucose monitoring market beyond 2025 anticipates sustained growth, fueled by ongoing technological advancements in device accuracy and connectivity. The development of integrated diabetes management systems combining CGM with insulin delivery and data analytics is a significant trend. Furthermore, the rise of telehealth and remote patient monitoring solutions further supports home-based glucose monitoring, driving market expansion. Competition amongst established players and emerging companies will likely intensify, leading to innovations in device design, functionality, and affordability. Addressing affordability concerns through innovative payment models and wider insurance coverage could unlock substantial untapped market potential and accelerate growth throughout the forecast period. Future market analyses should focus on the emergence of artificial intelligence (AI) driven glucose prediction algorithms and the evolving landscape of regulatory approvals for novel devices to fully capture the market's dynamic evolution.
North America Blood Glucose Monitoring Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the North America Blood Glucose Monitoring market, encompassing market dynamics, growth trends, regional segmentation, product landscape, key players, and future outlook. The study period covers 2019-2033, with 2025 as the base year and a forecast period of 2025-2033. The report is invaluable for industry professionals, investors, and strategic decision-makers seeking to understand and capitalize on the opportunities within this dynamic market. The market is segmented by Device (Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring [CGM]), Lancets, and End User (Hospital/Clinics, Home/Personal). The total market size is estimated at XX Million units in 2025.
North America Blood Glucose Monitoring Market Dynamics & Structure
The North American blood glucose monitoring market is characterized by a moderately concentrated landscape, with key players such as Abbott Diabetes Care, Medtronic, Dexcom, and Ascensia Diabetes Care holding significant market share. The market exhibits robust growth driven by the rising prevalence of diabetes, technological advancements in continuous glucose monitoring (CGM), and increasing government initiatives to improve diabetes management. However, high device costs, reimbursement challenges, and the need for continuous calibration in some CGM devices pose significant barriers.
Market Structure & Dynamics:
- Market Concentration: Moderate, with top 7 companies holding approximately 72% market share in 2025 (estimated).
- Technological Innovation: Continuous advancements in CGM technology, including improved accuracy, smaller sensor sizes, and integration with insulin pumps, are key drivers.
- Regulatory Landscape: FDA approvals and guidelines significantly impact market access and adoption of new products.
- Competitive Substitutes: Limited direct substitutes exist, but lifestyle modifications and alternative therapies compete indirectly.
- End-User Demographics: The aging population and rising prevalence of type 2 diabetes are major contributors to market growth.
- M&A Activity: Moderate M&A activity has been observed, with strategic acquisitions aimed at expanding product portfolios and geographic reach. XX M&A deals were recorded between 2019 and 2024 (estimated).
North America Blood Glucose Monitoring Market Growth Trends & Insights
The North America blood glucose monitoring market experienced substantial growth during the historical period (2019-2024), driven by factors such as increasing diabetes prevalence, technological advancements in CGM systems, and growing awareness of self-monitoring importance. The market is projected to maintain a strong CAGR of xx% during the forecast period (2025-2033), reaching an estimated market size of xx million units by 2033. This growth is fueled by the increasing adoption of CGM systems, particularly among younger populations and those with type 1 diabetes. Consumer preferences are shifting towards more convenient and user-friendly devices with improved accuracy and integration with mobile applications. Technological disruptions, such as the development of implantable sensors and AI-driven analytics, are poised to further revolutionize the market. Market penetration of CGM is expected to increase from xx% in 2025 to xx% by 2033.
Dominant Regions, Countries, or Segments in North America Blood Glucose Monitoring Market
The United States holds the largest market share in North America, driven by high diabetes prevalence, robust healthcare infrastructure, and greater access to advanced technologies. Within the segments, Continuous Glucose Monitoring (CGM) is experiencing faster growth compared to self-monitoring blood glucose devices (SMBG), owing to its continuous data provision and improved clinical outcomes. The Home/Personal end-user segment dominates, reflecting the increasing emphasis on self-management of diabetes.
Key Drivers:
- United States: High diabetes prevalence, advanced healthcare infrastructure, and strong regulatory support.
- CGM Segment: Improved accuracy, convenience, and potential for better glycemic control.
- Home/Personal Segment: Growing preference for self-management and home-based monitoring.
North America Blood Glucose Monitoring Market Product Landscape
The market offers a range of products, including SMBG devices (meters and strips), lancets, and CGM systems. Recent innovations focus on improving accuracy, reducing sensor size, extending sensor lifespan, and integrating devices with mobile apps for data management and remote monitoring. Key selling propositions include ease of use, accuracy, integration capabilities, and data analysis features. Technological advancements like non-invasive glucose monitoring are emerging but are not yet commercially widespread.
Key Drivers, Barriers & Challenges in North America Blood Glucose Monitoring Market
Key Drivers:
- Rising prevalence of diabetes
- Technological advancements in CGM
- Government initiatives promoting diabetes management
- Growing awareness of self-monitoring importance
Challenges and Restraints:
- High cost of devices and consumables, limiting affordability and access for certain demographics.
- Reimbursement complexities and insurance coverage variability hinder widespread adoption.
- Stringent regulatory approvals can delay product launches and increase development costs.
- Intense competition among established and emerging players.
Emerging Opportunities in North America Blood Glucose Monitoring Market
- Expansion into underserved populations and rural areas.
- Development of integrated diabetes management systems combining CGM with insulin delivery.
- Integration of AI and machine learning for predictive analytics and personalized treatment plans.
- Growing demand for remote monitoring and telehealth solutions.
Growth Accelerators in the North America Blood Glucose Monitoring Market Industry
Technological breakthroughs in sensor technology, miniaturization, and data analytics are key growth drivers. Strategic partnerships between device manufacturers, pharmaceutical companies, and healthcare providers are accelerating market growth. Expanding market access through improved insurance coverage and government initiatives further fuels market expansion.
Key Players Shaping the North America Blood Glucose Monitoring Market Market
- Abbott Diabetes Care
- Medisana
- Medtronic
- Trivida
- Acon
- Rossmax
- Agamatrix Inc
- F Hoffmann-La Roche AG
- Bionime Corporation
- Johnson & Johnson
- Arkray
- Dexcom
- Ascensia Diabetes Care
Notable Milestones in North America Blood Glucose Monitoring Market Sector
- December 2022: Dexcom G7 CGM receives FDA approval for all types of diabetes in individuals aged two and older.
- March 2023: Modified Abbott CGM sensors receive FDA approval for use in automated insulin delivery systems.
In-Depth North America Blood Glucose Monitoring Market Outlook
The North America blood glucose monitoring market is poised for sustained growth, driven by continuous technological innovation, increasing diabetes prevalence, and expanding access to care. Strategic partnerships, improved reimbursement policies, and the development of integrated diabetes management systems will further accelerate market expansion. The market presents significant opportunities for companies that can offer innovative, affordable, and user-friendly solutions.
North America Blood Glucose Monitoring Market Segmentation
-
1. Device
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose Devices
-
2. End User
- 2.1. Hospital/Clinics
- 2.2. Home/Personal
-
3. Geography
- 3.1. United States
- 3.2. Canada
- 3.3. Rest of North America
North America Blood Glucose Monitoring Market Segmentation By Geography
- 1. United States
- 2. Canada
- 3. Rest of North America
North America Blood Glucose Monitoring Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 13.13% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Continuous Glucose Monitoring Holds Highest Market Share in the North American Blood Glucose Monitoring Market.
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Device
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by End User
- 5.2.1. Hospital/Clinics
- 5.2.2. Home/Personal
- 5.3. Market Analysis, Insights and Forecast - by Geography
- 5.3.1. United States
- 5.3.2. Canada
- 5.3.3. Rest of North America
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. United States
- 5.4.2. Canada
- 5.4.3. Rest of North America
- 5.1. Market Analysis, Insights and Forecast - by Device
- 6. United States North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Device
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by End User
- 6.2.1. Hospital/Clinics
- 6.2.2. Home/Personal
- 6.3. Market Analysis, Insights and Forecast - by Geography
- 6.3.1. United States
- 6.3.2. Canada
- 6.3.3. Rest of North America
- 6.1. Market Analysis, Insights and Forecast - by Device
- 7. Canada North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Device
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by End User
- 7.2.1. Hospital/Clinics
- 7.2.2. Home/Personal
- 7.3. Market Analysis, Insights and Forecast - by Geography
- 7.3.1. United States
- 7.3.2. Canada
- 7.3.3. Rest of North America
- 7.1. Market Analysis, Insights and Forecast - by Device
- 8. Rest of North America North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Device
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by End User
- 8.2.1. Hospital/Clinics
- 8.2.2. Home/Personal
- 8.3. Market Analysis, Insights and Forecast - by Geography
- 8.3.1. United States
- 8.3.2. Canada
- 8.3.3. Rest of North America
- 8.1. Market Analysis, Insights and Forecast - by Device
- 9. United States North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 10. Canada North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 11. Mexico North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 12. Rest of North America North America Blood Glucose Monitoring Market Analysis, Insights and Forecast, 2019-2031
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2024
- 13.2. Company Profiles
- 13.2.1 Abbott Diabetes Care
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 Medisana
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Medtronic
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Trivida
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Acon
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Rossmax*List Not Exhaustive 7 2 Company Share Analysi
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 Agamatrix Inc
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 F Hoffmann-La Roche AG
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Bionime Corporation
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.10 Johnson & Johnson
- 13.2.10.1. Overview
- 13.2.10.2. Products
- 13.2.10.3. SWOT Analysis
- 13.2.10.4. Recent Developments
- 13.2.10.5. Financials (Based on Availability)
- 13.2.11 Arkray
- 13.2.11.1. Overview
- 13.2.11.2. Products
- 13.2.11.3. SWOT Analysis
- 13.2.11.4. Recent Developments
- 13.2.11.5. Financials (Based on Availability)
- 13.2.12 Dexcom
- 13.2.12.1. Overview
- 13.2.12.2. Products
- 13.2.12.3. SWOT Analysis
- 13.2.12.4. Recent Developments
- 13.2.12.5. Financials (Based on Availability)
- 13.2.13 Ascensia Diabetes Care
- 13.2.13.1. Overview
- 13.2.13.2. Products
- 13.2.13.3. SWOT Analysis
- 13.2.13.4. Recent Developments
- 13.2.13.5. Financials (Based on Availability)
- 13.2.1 Abbott Diabetes Care
List of Figures
- Figure 1: North America Blood Glucose Monitoring Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: North America Blood Glucose Monitoring Market Share (%) by Company 2024
List of Tables
- Table 1: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Device 2019 & 2032
- Table 3: North America Blood Glucose Monitoring Market Revenue Million Forecast, by End User 2019 & 2032
- Table 4: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 5: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Country 2019 & 2032
- Table 7: United States North America Blood Glucose Monitoring Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Canada North America Blood Glucose Monitoring Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Mexico North America Blood Glucose Monitoring Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Rest of North America North America Blood Glucose Monitoring Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Device 2019 & 2032
- Table 12: North America Blood Glucose Monitoring Market Revenue Million Forecast, by End User 2019 & 2032
- Table 13: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 14: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Country 2019 & 2032
- Table 15: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Device 2019 & 2032
- Table 16: North America Blood Glucose Monitoring Market Revenue Million Forecast, by End User 2019 & 2032
- Table 17: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 18: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Country 2019 & 2032
- Table 19: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Device 2019 & 2032
- Table 20: North America Blood Glucose Monitoring Market Revenue Million Forecast, by End User 2019 & 2032
- Table 21: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Geography 2019 & 2032
- Table 22: North America Blood Glucose Monitoring Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Blood Glucose Monitoring Market?
The projected CAGR is approximately 13.13%.
2. Which companies are prominent players in the North America Blood Glucose Monitoring Market?
Key companies in the market include Abbott Diabetes Care, Medisana, Medtronic, Trivida, Acon, Rossmax*List Not Exhaustive 7 2 Company Share Analysi, Agamatrix Inc, F Hoffmann-La Roche AG, Bionime Corporation, Johnson & Johnson, Arkray, Dexcom, Ascensia Diabetes Care.
3. What are the main segments of the North America Blood Glucose Monitoring Market?
The market segments include Device, End User, Geography.
4. Can you provide details about the market size?
The market size is estimated to be USD 15.51 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Continuous Glucose Monitoring Holds Highest Market Share in the North American Blood Glucose Monitoring Market..
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
March 2023: Modified Abbott CGM sensors scored FDA nod for use in automated insulin delivery systems.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "North America Blood Glucose Monitoring Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the North America Blood Glucose Monitoring Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the North America Blood Glucose Monitoring Market?
To stay informed about further developments, trends, and reports in the North America Blood Glucose Monitoring Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
